Science Progress | Where science, technology, and progressive policy meet

Life Sciences, Health & Bioethics Articles

June 24, 2013


Your Genes Not for Sale

The Supreme Court, in denying Myriad the ability to patent human genes, has reaffirmed that some discoveries are inventions worthy of private ownership and others are simply part of the laws of nature.

May 23, 2013


Fetal Anomalies, Undue Burdens, and 20-week Abortion Bans

20-week abortions bans scale back late-term abortions despite ample evidence that fetal anomalies, particularly those that are lethal, are detected between 18-24 weeks, forcing women to carry nonviable fetuses to term at their own peril.

April 26, 2013


On the Ethics of Publishing Genomes

A story that began in 1951 and continues to play out today reminds us that it’s very difficult, if not impossible, to guarantee the long-term confidentiality of genetic information.

January 24, 2013


Blue Pill or Red Pill?

The electronic medical record could save the clinical trial, cut health care costs, and improve the value of research.

January 11, 2013


Supreme Court Allows Assault On Stem Cell Research To Die

This week, the Supreme Court announced it would refuse to hear arguments seeking to ban federally funded research using embryonic stem cells, effectively setting the issue of limited federal funding for such research to rest.

December 18, 2012


The Tricky Business of Defining Mental Disorders

As the nation reflects in the wake of a the horrific shooting at Sandy Hook Elementary, the American Psychiatric Association is preparing to release a major revision to its classification system for mental disorders.

November 13, 2012


U.S. Stem Cell Research Policies in Need of an Update

While the infamous stem cell research case of Sherley v. Sebelius receives yet another ruling in the DC Circuit, questions remain about the usefulness of the Dickey-Wicker Amendment in the face of rapidly changing science.

September 4, 2012


Looking for Cures Lost in Translation

Surprisingly few of the billions of federal dollars spent on biomedical research go toward translating basic science discoveries into workable therapies. But a brand new NIH program is taking small steps in the right direction.

August 30, 2012


Biotech is Thrusting Us into New Political Territory

Think you know your left from right, in the debate over 21st century biopolitics? When it comes to biotechnology, think again. Stem cells, embryo research and synthetic biology are just a few of the issues that will force strange new political alliances

August 20, 2012

The Hard Path to Open Source Bioinnovation

The “open source” software movement may have created your browser, it you’re using Firefox. But the open source movement in biotechnology is less well-known. This article explains why.

August 13, 2012


The Problems With Pre-Exposure HIV Prevention

A revolutionary new pill substantially reduces the risk of HIV infection if taken properly, but could also lead to more risky behavior and higher rates of infection if taken improperly. What’s a drug-maker to do?

July 30, 2012


Neuroethics 101

Applied neuroscience—from neuromarketing, to mind-reading, to cognitive lifestyle enhancement— is rapidly becoming a reality affecting commerce, national security, and culture. This primer looks at where we are going, and what we need to look out for.